Skip to content
LexBuild

Gastrointestinal Drugs Advisory Committee; Cancellation

---
identifier: "/us/fr/E9-11725"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Gastrointestinal Drugs Advisory Committee; Cancellation"
title_number: 0
title_name: "Federal Register"
section_number: "E9-11725"
section_name: "Gastrointestinal Drugs Advisory Committee; Cancellation"
positive_law: false
currency: "2009-05-19"
last_updated: "2009-05-19"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E9-11725"
document_type: "notice"
publication_date: "2009-05-19"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "74 FR 23426"
fr_volume: 74
docket_ids:
  - "Docket No. FDA-2009-N-0664"
fr_action: "Notice."
---

#  Gastrointestinal Drugs Advisory Committee; Cancellation

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The meeting of the Gastrointestinal Drugs Advisory Committee scheduled for May 20, 2009, is cancelled. This meeting was announced in the *Federal Register* of April 7, 2009 (74 FR 15739). The FDA's Center for Drug Evaluation and Research is continuing to review the application that was going to be discussed by the committee.

**FOR FURTHER INFORMATION CONTACT:**

Kristine T. Khuc, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5630 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, e-mail: *[email protected]* , or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512538. Please call the Information Line for up-to-date information on this meeting.

Dated: May 14, 2009.

Randall W. Lutter,

Deputy Commissioner for Policy.